Captor Therapeutics S.A. (CTX)
GPW
Closed
Aug 25, 2026
Day's Range
69.7052 wk Range
33.00Overview - CTX - Captor Therapeutics S.A.
Key Statistics
Valuation
Enterprise Value
449.10M
P/E (Trailing)
‪-9.46‬
P/E (Forward)
‪-276.92‬
PEG Ratio
‪-1.84‬
Price / Sales (TTM)
‪194.09‬
Price / Book
‪33.62‬
EV / EBITDA
‪-11.18‬
Profitability
Gross Margin
‪100.00%‬
Profit Margin
‪68.99%‬
Operating Margin
‪-3,433.53%‬
Return on Assets
‪-55.12%‬
Return on Equity
‪-128.86%‬
Ownership
Shares Outstanding
5.53M
Float
4.46M
Held by Insiders
‪29.30%‬
Held by Institutions
‪29.65%‬
Price stats
Beta
‪0.55‬
50-Day Avg
‪74.44‬
200-Day Avg
‪74.86‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪PLN 86.83‬Market Cap - CTX - Captor Therapeutics S.A.
Peers - CTX - Captor Therapeutics S.A.
Peer Comparison
Compared with companies in Biotechnology listed on GPW.
- CTXGPWCaptor Therapeutics S.A.449.67MMarket Cap+43.24%52-week change-9.33P/E (Trailing)‪68.99%‬Profit Margin
- BSTGPWBest S.A.974.02MMarket Cap+25.15%52-week change7.34P/E (Trailing)‪23.56%‬Profit Margin
- BCXGPWBioceltix S.A.442.58MMarket Cap-33.33%52-week change-26.24P/E (Trailing)‪0.00%‬Profit Margin
- BIOGPWBioton S.A.323.70MMarket Cap-11.14%52-week change75.40P/E (Trailing)‪1.52%‬Profit Margin
- APEGPWAps Energia S.A.156.71MMarket Cap+46.94%52-week change15.44P/E (Trailing)‪10.72%‬Profit Margin
- ASBPGPWAspire Biopharma Holdings Inc.7.83MMarket Cap-151.90%52-week change-0.01P/E (Trailing)‪-1.87%‬Profit Margin
- ASEPGPWAsep Medical Holdings Inc.1.44MMarket Cap-284.62%52-week change-0.10P/E (Trailing)‪-538.03%‬Profit Margin
Profile Summary - CTX - Captor Therapeutics S.A.
About
Captor Therapeutics S.A. is an innovative biotechnology company specializing in the development of targeted protein degradation technologies aimed at treating serious medical conditions. Its primary function is to address diseases that do not respond well to traditional small molecule drugs, offering novel therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
